Preclinical Imaging Market By Type of Product, Micro Computed Tomography, Magnetic Particle Imaging, Magnetic Resonance Imaging, Optical Imaging, X-Ray Imaging, Positron Emission Tomography, Ultrasound, Reagents and Kits, Others), By Application, By End User, and Region Forecast 2019-2030

download arrow download arrow Download Free Sample
settings arrow settings arrow email us

Preclinical Imaging Market Size, Share, Growth, Trends, and Global Industry Analysis: By Type of Product (Imaging Modalities, Single Photon emission computed tomography (SPECT), Micro Computed Tomography (Micro-CT), Magnetic Particle Imaging, Magnetic Resonance Imaging (MRI), Optical Imaging, X-Ray Imaging, Positron Emission Tomography (PET), Ultrasound , Reagents and Kits, Others), By Application (Research and Development, Drug Discovery), By End User (Biotech Companies, Pharmaceutical companies, Research institutes), and Region Forecast 2019-2030

checked icon arrow_drop_down
checked icon Single User License $4400 $3520
checked icon Multiple User License $6600 $5280
checked icon Corporate User License $8900 $7120

Preclinical Imaging Market size was valued at US$ 870.4 million in 2023, growing at a CAGR of 7.1% from 2024-2030. Preclinical imaging is used during drug discovery process in live animals. Preclinical imaging used for monitoring the treatment regime responses helpful for obtaining the early indications of efficacy. Technological improvements and advances in in-vivo clinical study providing the new opportunities to understand the clearly molecular level of details. Major preclinical imaging is targeted for diseases such as autoimmune diseases, cancers, cardiovascular diseases, and neurological disorders and others. Surge in adoption of sophisticated diagnostic technologies coupled with increased early diagnosis have expected to accelerate global market.

According to American Cancer Society, 14.1 million new cancer cases were diagnosed and 8.2 million cancer deaths in 2012. Companies adopting product innovations to increase their market share. Currently, the most used imaging modalities are optical (fluorescence and bioluminescence), PET, and MRI. In addition, multi-modalities such as PET+CT and SPECT+CT are the most used imaging combinations. In-vivo imaging is increased usage in target identification, compound optimization and pre-Phase I study, and in the drug development process. Thus, it bridges the gap between in-vitro exploratory and in-vivo clinical research. Regions such as Latin America, Middle East, and Asia Pacific are witnessing an increase in foreign investments that is leading to greater revenue generation, for the market growth.

Key Developments

  • In September 2016, Bruker Corporation signed an agreement to acquire the preclinical imaging business of Oncovision to increase their product portfolio .
  • In March 2017, MR solutions introduced 9.4 tesla cryogen preclinical MRI imaging solution for cardiovascular sector In February 2016, TriFoil Imaging installed InSyTe FLECT/CT Russia first 3D Optical imaging system at Novosibirsk

summary download arrow Download Free Sample

Global Preclinical Imaging Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

7.1%

Largest Market

North America

Fastest Growing Market

Europe

Preclinical Imaging Market Dynamics

Rise in the number of contract research organizations (CRO), innovations in the devices used for small imaging technological advancements, and increase in number of drug trials due to rise in the incidence and prevalence of chronic diseases such as rheumatoid arthritis, cancer, cardiovascular & neurological disorders are some of the factors bolstering the market growth. The huge cost of equipment, lack of skilled personnel to handle the equipment and lack of proper infrastructure are hindering the growth of the market. Furthermore, restrictions on animal drug testing by animal rights organizations are the major factors hampering growth of the market.

Global Preclinical Imaging Market Segmentation Analysis

Report Benchmarks

Details

Report Study Period

2024-2030

Market Size in 2023

US$ 870.4 million

Market CAGR

7.1%

By Product Type

  • Imaging Modalities
  • Single Photon emission computed tomography (SPECT)
  • Micro Computed Tomography (Micro-CT)
  • Magnetic Particle Imaging
  • Magnetic Resonance Imaging (MRI)
  • Optical Imaging
  • X-Ray Imaging
  • Positron Emission Tomography (PET)
  • Ultrasound
  • Others
  • Reagents and Kits

By Application

  • Research and Development
  • Drug Discovery

By End User

  • Biotech Companies
  • Pharmaceutical companies
  • Research institutes

By Region

  • North America (U.S., Canada)
  • Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
  • Asia-Pacific (China, India, Japan, Australia, Southeast Asia, Rest of Asia Pacific)
  • Latin America (Mexico, Brazil, Argentina, Columbia, Rest of Latin America)
  • Middle East & Africa (GCC, Egypt, Nigeria, South Africa, Rest of Middle East and Africa)

Key Features of the Report

  • The preclinical imaging market report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitor's overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
  • The report analyses the impact of the socio-political environment through PESTLE Analysis and competition through Porter's Five Force Analysis 

Download Free Sample Report

I accept the Terms and Conditions,Disclaimers, GDPR Policy

Frequently Asked Questions

The global preclinical imaging market size was valued at US$ 870.4 million in 2023 and is projected to grow at a CAGR of 7.1% from 2024 to 2030.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

The key players of the report are FUJIFILM Holdings Corporation (Japan), MR Solutions (U.K.), PerkinElmer Inc. (U.S.),, Siemens Ltd (U.S.),, Miltenyi Biotec (Germany),, Aspect Imaging (Canada),, MILabs B.V. (Netherlands),, Bruker Corporation (U.S.),, Mediso Ltd. (Hungary),, TriFoil Imaging (U.S.),, Carestream Health (U.S.)

Author image

Author

Muni Kumar Meravath

Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....

1. Executive Summary
2. Global Preclinical Imaging Market Introduction
2.1. Global Preclinical Imaging Market – Taxonomy
2.2. Global Preclinical Imaging Market –Definitions
2.2.1. Product
2.2.2. Application
3. Global Preclinical Imaging Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Preclinical Imaging Market Dynamic Factors - Impact Analysis
3.6. Global Preclinical Imaging Market – Competition Landscape
4. Global Preclinical Imaging Market Analysis, 2019-2023 and Forecast, 2024-2030
4.1. Market Analysis,2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global Preclinical Imaging Market, By Product, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn)
5.1. Medical Devices
5.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. CT Imaging
5.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. MRI Imaging
5.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
5.4. PET/SPECT Imaging
5.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn)
5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.3. Market Opportunity Analysis
5.5. Multi-modal Imaging
5.5.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn)
5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.5.3. Market Opportunity Analysis
5.6. Optical Imaging
5.6.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn)
5.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.6.3. Market Opportunity Analysis
5.7. Ultrasound Imaging
5.7.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn)
5.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.7.3. Market Opportunity Analysis
5.8. Photoacoustic (PAT) Imaging
5.8.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn)
5.8.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.8.3. Market Opportunity Analysis
5.9. Reagents
5.9.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn)
5.9.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.9.3. Market Opportunity Analysis
5.10. Services
5.10.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn)
5.10.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.10.3. Market Opportunity Analysis
6. Global Preclinical Imaging Market, By Application, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn)
6.1. Hospitals
6.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Diagnostics Centers
6.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Others
6.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
7. Global Preclinical Imaging Market Forecast, By Region, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn)
7.1. North America
7.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Europe
7.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Asia-Pacific
7.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
7.4. Latin America
7.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn)
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.4.3. Market Opportunity Analysis
7.5. Middle East and Africa
7.5.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn)
7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.5.3. Market Opportunity Analysis
7.6. Global Preclinical Imaging Market - Opportunity Analysis Index, By Product, Application and Region, 2024-2030
8. North America Preclinical Imaging MarketAnalysis,2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn)
8.1. By Product Analysis 2019-2023 and Forecast 2024-2030by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
8.1.1. Medical Devices
8.1.2. CT Imaging
8.1.3. MRI Imaging
8.1.4. PET/SPECT Imaging
8.1.5. Multi-modal Imaging
8.1.6. Optical Imaging
8.1.7. Ultrasound Imaging
8.1.8. Photoacoustic (PAT) Imaging
8.1.9. Reagents
8.1.10. Services
8.2. Application Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
8.2.1. Hospitals
8.2.2. Diagnostics Centers
8.2.3. Others
8.3. Country Analysis 2019-2023 and Forecast 2024-2030by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
8.3.1. USA
8.3.2. Canada
8.4. North America Preclinical Imaging Market - Opportunity Analysis Index, By  Product, Application, and Country, 2024-2030
8.5. North America Preclinical Imaging Market Dynamics – Trends
9. Europe Preclinical Imaging Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn)
9.1. By Product Analysis 2019-2023 and Forecast 2024-2030by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
9.1.1. Medical Devices
9.1.2. CT Imaging
9.1.3. MRI Imaging
9.1.4. PET/SPECT Imaging
9.1.5. Multi-modal Imaging
9.1.6. Optical Imaging
9.1.7. Ultrasound Imaging
9.1.8. Photoacoustic (PAT) Imaging
9.1.9. Reagents
9.1.10. Services
9.2. Application Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
9.2.1. Hospitals
9.2.2. Diagnostics Centers
9.2.3. Others
9.3. Country Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
9.3.1. Germany
9.3.2. UK
9.3.3. France
9.3.4. Spain
9.3.5. Italy
9.3.6. Russia
9.3.7. Poland
9.3.8. Rest of Europe
9.4. Europe Preclinical Imaging Market - Opportunity Analysis Index, By  Product, Application, and Country, 2024-2030
9.5. Europe Preclinical Imaging Market Dynamics – Trends
10. Asia-Pacific Preclinical Imaging Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn)
10.1. By Product Analysis 2019-2023 and Forecast 2024-2030by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
10.1.1. Medical Devices
10.1.2. CT Imaging
10.1.3. MRI Imaging
10.1.4. PET/SPECT Imaging
10.1.5. Multi-modal Imaging
10.1.6. Optical Imaging
10.1.7. Ultrasound Imaging
10.1.8. Photoacoustic (PAT) Imaging
10.1.9. Reagents
10.1.10. Services
10.2. Application Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.2.1. Hospitals
10.2.2. Diagnostics Centers
10.2.3. Others
10.3. Country Analysis2019-2023 and Forecast 2024-2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.3.1. Japan
10.3.2. China
10.3.3. India
10.3.4. ASEAN
10.3.5. Australia & New Zealand
10.3.6. Rest of Asia-Pacific
10.4. Asia-Pacific Preclinical Imaging Market - Opportunity Analysis Index, By  Product, Application, and Country, 2024-2030
10.5. Asia-Pacific Preclinical Imaging Market Dynamics – Trends
11. Latin America Preclinical Imaging Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn)
11.1. By Product Analysis 2019-2023 and Forecast 2024-2030by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
11.1.1. Medical Devices
11.1.2. CT Imaging
11.1.3. MRI Imaging
11.1.4. PET/SPECT Imaging
11.1.5. Multi-modal Imaging
11.1.6. Optical Imaging
11.1.7. Ultrasound Imaging
11.1.8. Photoacoustic (PAT) Imaging
11.1.9. Reagents
11.1.10. Services
11.2. Application Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.2.1. Hospitals
11.2.2. Diagnostics Centers
11.2.3. Others
11.3. Country Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.3.1. Brazil
11.3.2. Mexico
11.3.3. Argentina
11.3.4. Rest of Latin America
11.4. Latin America Preclinical Imaging Market - Opportunity Analysis Index, By  Product, Application, and Country, 2024-2030
11.5. Latin America Preclinical Imaging Market Dynamics – Trends
12. Middle East and Africa Preclinical Imaging Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn)
12.1. By Product Analysis 2019-2023 and Forecast 2024-2030by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
12.1.1. Medical Devices
12.1.2. CT Imaging
12.1.3. MRI Imaging
12.1.4. PET/SPECT Imaging
12.1.5. Multi-modal Imaging
12.1.6. Optical Imaging
12.1.7. Ultrasound Imaging
12.1.8. Photoacoustic (PAT) Imaging
12.1.9. Reagents
12.1.10. Services
12.2. Application Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.2.1. Hospitals
12.2.2. Diagnostics Centers
12.2.3. Others
12.3. Country Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.3.1. Gulf Cooperation Council (GCC) Countries
12.3.2. Israel
12.3.3. South Africa
12.3.4. Rest of MEA
12.4. MEA Preclinical Imaging Market - Opportunity Analysis Index, By  Product, Application, and Country, 2024-2030
12.5. MEA Preclinical Imaging Market Dynamics – Trends
13. Competition Landscape 
13.1. Strategic Dashboard of Top Market Players
13.2. Company Profiles (Introduction, Financial Analysis, Technology & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
13.2.1. Bruker Corporation
13.2.2. Siemens A.G.
13.2.3. General Electric(GE)
13.2.4. Trifoil Imaging
13.2.5. PerkinElmer Inc.
13.2.6. Agilent Technologies
13.2.7. MILabs B.V
13.2.8. Fujifilm Holdings Corporation
13.2.9. MR Solutions Ltd
13.2.10. Li-Cor Biosciences
13.2.11. Mediso Ltd
13.2.12. Milabs BV
14. Research Methodology
15. Key Assumptions and Acronyms

Key Market Players

  • FUJIFILM Holdings Corporation (Japan),
  • MR Solutions (U.K.),
  • PerkinElmer Inc. (U.S.),
  • Siemens Ltd (U.S.),
  • Miltenyi Biotec (Germany),
  • Aspect Imaging (Canada),
  • MILabs B.V. (Netherlands),
  • Bruker Corporation (U.S.),
  • Mediso Ltd. (Hungary),
  • TriFoil Imaging (U.S.),
  • Carestream Health (U.S.)

Related Industry Reports

X-Ray Detector Market

Single Photon Emission Computed Tomography Market

Optical Imaging Market

Global Diagnostic Imaging Market